MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonifácio, M. J.
Right arrow Articles by Soares-da-Silva, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonifácio, M. J.
Right arrow Articles by Soares-da-Silva, P.

Vol. 62, Issue 4, 795-805, October 2002

Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application

Maria João Bonifácio, Margarida Archer, Maria L. Rodrigues, Pedro M. Matias, David A. Learmonth, Maria Arménia Carrondo, and Patrício Soares-da-Silva

Department of Research and Development, BIAL, S. Mamede do Coronado, Portugal (M.J.B., D.A.L., P.S.S.); Instituto de Tecnologia Química e Biológica-Universidade Nova de Lisboa, Oeiras, Portugal (M.A., M.L.R., P.M.M., M.A.C.); and Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal (M.A., M.L.R.)

Catechol-O-methyltransferase (COMT; E.C. 2.1.1.6) is a ubiquitous enzyme in nature that plays an important role in the metabolism of catechol neurotransmitters and xenobiotics. In particular, inactivation of drugs such as L-3,4-dihydroxyphenylalanine (L-DOPA) via O-methylation is of relevant pharmacological importance, because L-DOPA is currently the most effective drug used in the treatment of Parkinson's disease. This justified the interest in developing COMT inhibitors as potential adjuncts to L-DOPA therapy. The kinetics of inhibition by BIA 3-335 (1-[3,4-dihydroxy-5-nitrophenyl]-3-(N-3'-trifluormethylphenyl)-piperazine-1-propanone dihydrochloride) were characterized using recombinant rat soluble COMT. BIA 3-335 was found to act as a potent, reversible, tight-binding inhibitor of COMT with a Ki of 6.0 ± 1.6 nM and displaying a competitive inhibition toward the substrate binding site and uncompetitive inhibition toward the S-adenosyl-L-methionine (SAM) binding site. The 2.0-Å resolution crystal structure of COMT in complex with its cosubstrate SAM and a novel inhibitor BIA 3-335 shows the atomic interactions between the important residues at the active site and the inhibitor. This is the first report of a three-dimensional structure determination of COMT complexed with a potent, reversible, and tight-binding inhibitor that is expected to have therapeutic applications.


Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Protein Sci.Home page
M. Grana, A. Haouz, A. Buschiazzo, I. Miras, A. Wehenkel, V. Bondet, W. Shepard, F. Schaeffer, S. T. Cole, and P. M. Alzari
The crystal structure of M. leprae ML2640c defines a large family of putative S-adenosylmethionine-dependent methyltransferases in mycobacteria
Protein Sci., September 1, 2007; 16(9): 1896 - 1904.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. N. Palma, M. L. Rodrigues, M. Archer, M. J. Bonifacio, A. I. Loureiro, D. A. Learmonth, M. A. Carrondo, and P. Soares-da-Silva
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
Mol. Pharmacol., July 1, 2006; 70(1): 143 - 153.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. H. Cotton, B. Stoddard, and W. W. Parson
Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase
J. Biol. Chem., May 28, 2004; 279(22): 23710 - 23718.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. N. Palma, M. J. Bonifacio, A. I. Loureiro, L. C. Wright, D. A. Learmonth, and P. Soares-da-Silva
Molecular Modeling and Metabolic Studies of The Interaction of Catechol-O-Methyltransferase and a New Nitrocatechol Inhibitor
Drug Metab. Dispos., March 1, 2003; 31(3): 250 - 258.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics